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the third trimester or the post-partum period, and 95 % 
presented with chest pain. The main cause was coronary 
dissection (35 %), or thrombus/emboli (35 %) in the more 
contemporary group. Maternal mortality was 8 % (6 % in 
the contemporary group), and the main cardiac complica-
tion was ventricular tachycardia (n = 17). Premature deliv-
ery rate was 56 %, and caesarean section was performed 
in 57 %. Perinatal mortality was 4 %. In conclusion, IHD 
during pregnancy or in the post-partum period has high 
maternal mortality and morbidity rates. Also, premature 
delivery and perinatal mortality rates are high.
Keywords Ischemic heart disease · Pregnancy · Maternal
Introduction
Cardiovascular disease (CVD) is the leading cause of death 
in men and women in the Western world [1–3]; 50 % is due 
to ischaemic heart disease (IHD) [1]. Although pre-meno-
pausal women are relatively protected against atherosclero-
sis by their hormonal status, the risk of manifestations of IHD 
is increased during pregnancy and in the post-partum period 
[4–6]. This is due to cardiovascular and haemodynamic 
changes and hypercoagulability occurring during pregnancy 
[7–9]. CVD is the leading cause of indirect maternal death 
during pregnancy in Western countries with IHD, including 
acute myocardial infarction (AMI) as a frequent underlying 
disease [10, 11]. Previous studies estimated an incidence of 
IHD during pregnancy of 2.8–6.2 per 100,000 deliveries, 
3–4 times higher than the incidence found in non-pregnant 
women of reproductive age [4, 12].
Increasing maternal age and deteriorating lifestyle 
choices lead to a higher incidence of cardiac risk factors. 
Consequently, the incidence of IHD during pregnancy will 
Abstract The risk of manifestations of ischaemic heart 
disease (IHD) in fertile women is elevated during pregnan-
cy and the post-partum period. With increasing maternal 
age and a higher prevalence of cardiac risk factors, the in-
cidence of IHD during pregnancy is rising. However, infor-
mation in the literature is scarce. We therefore performed a 
retrospective cohort study and systematically reviewed the 
overall (1975–2013) and contemporary (2005–2013) lit-
erature concerning IHD presenting during pregnancy or in 
the post-partum period. We report two cases of IHD with 
atypical presentation during pregnancy or post-partum. In 
our review, we describe 146 pregnancies, including 57 con-
temporary cases (2005–2013). Risk factors for IHD were 
present in 80 %. Of the cases of IHD, 71 % manifested in 
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increase worldwide [13, 14]. However, information about 
IHD presenting during pregnancy is scarce. Incomplete 
information is available concerning aetiology of IHD, time 
of presentation and maternal and offspring outcomes [4–6]. 
We therefore present two cases of women in whom IHD 
presented during pregnancy or the post-partum period. Fur-
thermore, we systematically reviewed the literature about 
IHD presenting during pregnancy or in the post-partum 
period. Additionally, we will present a significant subset of 
contemporary cases separately.
Methods
For our case series, we performed a retrospective cohort 
study. All data were obtained by a systematic search of 
databases and matching of cardiology department and gyn-
aecology department databases in the University Medical 
Centre Groningen, Amsterdam Medical Centre and Uni-
versity Medical Centre Utrecht, all in the Netherlands. 
Diagnostic database matching codes were angina pectoris, 
ST-segment elevation myocardial infarction (STEMI), non-
STEMI, follow-up after myocardial infarction, follow-up 
after coronary artery bypass grafting and follow-up after 
percutaneous intervention (PCI). Women who presented 
with a first manifestation of IHD after conception until 6 
weeks post-partum in a 10-year period (2002–2012) were 
included, regardless of duration, outcome and course of the 
pregnancy. IHD was defined according to European Soci-
ety of Cardiology (ESC)/American College of CArdiology/
American Heart Association criteria [15]. Women with sig-
nificant congenital coronary abnormalities were excluded. 
Retrospective cohort studies do not need to be approved by 
the institutional review board in the Netherlands.
For our systematic review, we used the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses state-
ment protocol [16]. We researched the MEDLINE Public 
Database for all studies dated until 10 April 2013. Search 
terminology was Myocardial ischemia and Pregnancy, 
both in MeSH terms (‘Myocardial Ischemia’ [MeSH] AND 
‘Pregnancy’ [ MeSH]) and full text (Myocardial ischemia 
AND pregnancy). The filters Humans, Case Reports, Meta-
Analysis, Clinical Trial, Randomized Controlled Trial, 
Dutch, English, German, Female, MEDLINE, Adult: 19+ 
years and Adolescent: 13–18 years were activated. We only 
included studies written in English, German and Dutch 
to reduce misinterpretation of data. Systematic reviews 
were excluded, but new cases described in reviews were 
included. Cases described before 1975 were excluded. We 
included all online available articles, either from open-
access publishing or availability provided by the University 
Medical Centre Groningen. Articles describing myocardial 
ischaemia before pregnancy, ischaemia induced by medica-
tion or pheochromocytoma or that caused by Kawasaki’s or 
Takotsubo syndrome were excluded.
In both our case series as well as our systematic review, 
we collected data concerning the timing, cause and treat-
ment of IHD, comorbidities, risk factors for IHD and 
maternal cardiac and obstetric outcome as well as offspring 
outcome. Prematurity of the foetus was defined as birth at 
< 37 weeks of gestation, low birth weight was defined as 
weight < 2500 g and small for gestational age was defined 
as birth weight < 10th percentile. Perinatal mortality was 
defined as offspring death from 20 weeks of gestation up to 
7 days post-partum. We described cases published in or after 
2005 and not included in the latest review [6] separately, 
and we compared these contemporary cases with previous 
literature. Statistical analysis was performed using IBM 
SPSS Statistics Premium V 20 for Windows (IBM Corp., 
Released 2011; IBM SPSS Statistics for Windows, ver-
sion 20.0; Armonk, NY, USA). Missing data were excluded 
for analysis. Continuous data are presented as means with 
standard deviation (SD) or median with interquartile range 
(IQR) depending on their distribution. Absolute numbers 
and percentages were presented for categorical data. For 
comparison of categorical variables, the Fisher’s exact test 
or chi-square test was used.
Results
Case series
We identified two cases matching our inclusion and exclu-
sion criteria.
Our first case is a 25-year-old woman of Hispanic 
descent, with one previous miscarriage (gravida (G)2, para 
(P)0). The patient was severely obese with a body mass 
index of 39 kg/m2. She had a history of a transient ischaemic 
attack, suspected antiphospholipid syndrome and mitral 
valvuloplasty for mitral regurgitation due to non-bacterial 
endocarditis. She was referred to the cardiologist for pre-
pregnancy counselling. When she was pregnant, her vitamin 
K antagonist was replaced by acetylsalicylic acid and a full 
dose of low-molecular-weight heparin during pregnancy 
until the fifth day post-partum. At 27 weeks of gestation, 
she presented with complaints of upper abdominal pain. She 
was diagnosed with pre-eclampsia complicated by haemol-
ysis, elevated liver enzymes and low platelet (HELLP) syn-
drome (alanine aminotransferase: 143 U/l, thrombocytes: 
128 × 109/l). Foetal ultrasonography showed normal growth 
and the foetal condition judged by cardiotocography was 
well. The patient was treated with labetalol and magnesium 
sulphate (MgSO4). At 29 + 3 weeks of gestation, her condi-
tion worsened, and a caesarean section was performed. She 
delivered a baby girl of 1067 g (50th percentile) with an 
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sclerotic occlusion of the left main coronary artery. She was 
treated with stenting of the left coronary artery and medi-
cally with acetylsalicylic acid, beta-blocker, clopidogrel and 
subcutaneous heparin. At 37 weeks of gestation, intrauterine 
growth retardation and placental insufficiency were sus-
pected. The decision was made to perform an elective caesar-
ean section. She delivered a live born neonate at 37 + 5 weeks. 
Neonatal Apgar score at 5 min was 10, and birth weight was 
2405 g, which is at the fifth percentile for gestational age. 
Histological examination of the placenta showed a small 
placenta (weight: < 10th percentile), with diffuse ischaemia, 
consistent with placental insufficiency. A statin was added to 
the maternal medical regimen during the post-partum period. 
Maternal ventricular function remained normal during 6 
months of follow-up. A stress test and nuclear scan revealed 
no signs of recurrent ischaemia. The neonate did well.
Systematic review
We found 128 articles describing IHD presenting during 
pregnancy and in the post-partum period, with a total of 
146 pregnancies, including 6 twin pregnancies and 1 trip-
let pregnancy. Inclusion is schematically presented in Fig. 1. 
Apgar score of 6 at 5 min. The neonate had to be admit-
ted to the neonatal intensive care unit because of prema-
turity. Three days post-partum, the mother presented with 
syncope. Chest pain was not reported. Electrocardiographic 
(ECG) monitoring showed ST-segment depression and Q 
waves, suggesting inferolateral AMI, which was confirmed 
by elevated troponin T (5.96 μg/l; normal: < 0.014 μg/l). Her 
coronary angiogram showed no abnormalities. The AMI was 
presumably caused by a thrombus, embolism or coronary 
spasm. Both mother and neonate survived. Her medication 
was upgraded to a beta-blocker, angiotensine I converting 
enzyme inhibitor, statin, acetylsalicylic acid and vitamin K 
antagonist. Echocardiography at 6 months showed a mildly 
reduced left ventricular function. The diagnosis of antiphos-
pholipid syndrome was confirmed.
Our second case is a 42-year-old woman, G1P0. She had 
a history of insulin-dependent diabetes mellitus, pulmo-
nary embolism and a positive family history for IHD. She 
was referred to a university hospital by an obstetric clinic at 
15 weeks of gestation because of an episode of ventricular 
tachycardia. Her ECG suggested anterior AMI, which was 
confirmed by raised troponin (37.77 μg/l) and creatine kinase 
(2239 U/l) levels. Her coronary angiogram revealed athero-
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Fig. 1 Flow diagram for inclu-
sion of literature (IHD ischaemic 
heart disease, CAD coronary ar-
tery disease, *exclusion based on 
abstract and title, **non-available 
articles were excluded)
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suggestive of AMI. In 89 % of cases, ST-segment deviation 
was seen on the ECG. In contrast to the overall group of 
women with IHD during pregnancy, where dissection was 
the most prevalent cause of IHD, in the contemporary group 
(n = 57), the incidences of thrombus or embolism and of dis-
section were comparable (20 versus 18 women; Table 2). 
Of the women who had AMI due to atherosclerosis, 93 % 
had one or more risk factors for IHD, compared with 43 % 
of the women who had AMI caused by coronary dissection 
(p < 0.001) and 68 % of women with thrombus or emboli 
(p < 0.01).
We excluded several studies for statistical analysis because 
of incomplete individual data concerning both cardiac and 
obstetric outcomes. The results of these studies are sum-
marised and compared with our results in a table and are 
discussed in our discussion section [4–6, 17–19]. All articles 
included were published between 1978 and 2012 and are pre-
sented in supplemental Table S1, which is available online.
Baseline characteristics
Baseline maternal characteristics are presented in Table 1.
IHD, characteristics and treatment
Characteristics of IHD during pregnancy, delivery or in the 
post-partum period are reported in Table 2. Comparison with 
other studies and characteristics of the contemporary group 
can be found in Table 3. All women experienced symptoms 
Table 1 Baseline characteristics of women with ischaemic heart dis-
ease presenting during pregnancy, according to the literature included 
in our review
N Mean (SD)
Pregnancies 146a
Age of woman 145 33.2 (5.8) years
Gravida 105 3.1 (2.0)
Parity 97 1.8 (1.6)
Coronary risk factors N (women) Percentage
 Smoking 50 40
 Dyslipidaemia 26 21
 Pre-pregnancy hypertension 24 20
 Family history 22 18
 Obesity (pre-pregnancy body mass 
index > 30 kgm2)
17 15
Diabetes mellitus 9 8
Use of illegal drugs before event 
(cocaine)
3 3
One or more risk factors 80 63
Two or more risk factors 44 34
Cardiac history
 Chest pain 11 9
 Valvular lesions 6 5
 Heart failure 2 2
 Supra-ventricular tachycardia 2 2
 Atrial fibrillation 2 2
 Pulmonary embolus 1 1
Concurrent conditions
 Thyroid disease 4 3
 Factor V Leiden 4 3
 Thrombophillia 2 2
 Connective tissue disease 2 2
 Infectious disease 1 1
 Other 19 12
Missing data were excluded for analysis
SD standard deviation
aIncluding six twin pregnancies and one triplet pregnancy
Table 2 Details of ischaemic heart disease and offspring outcomes in 
146 pregnancies (including 6 twin pregnancies and one triplet preg-
nancy) according to the literature included in our review
Presenting symptoms Number of 
pregnancies
Percentage
Chest pain 131 95
Dyspnoea 38 36
Syncope 10 9
Dizziness 10 10
Heart failure syndrome 6 6
Palpitations 1 1
Exercise intolerance 4 4
No symptoms 0 0
Location of AMI
Anterior, anteroseptal or anterolateral 80 67
Inferior, inferoposterior or inferolateral 22 19
Other 13 14
Presumed aetiology of IHD
Coronary dissection 46 35
Thrombus/embolism 33 25
Atherosclerosis/stenosis 31 24
Coronary spasm/other/unexplained 20 15
Timing of AMI
During pregnancy, first trimester 9 6
During pregnancy, second trimester 22 15
During pregnancy, third trimester 56 38
During post-partum period 50 33
During delivery 7 5
During pregnancy, unknown 2 1
Offspring outcome
Live born 128 96
Perinatal death 5 4
Premature birth 55 56
Low birth weight 19 40
Small for gestational age 1 2
Apgar score (at 5 min)
< 7 5 16
7–10 27 84
Perinatal death stands for intrauterine foetal death and stillborn
Premature birth is defined as birth at < 37 weeks of gestation, low 
birth weight is defined as weight <2500 g, small for gestational age is 
defined as birth weight < 10th percentile
Missing data were excluded for analysis
AMI acute myocardial infarction, IHD ischaemic heart disease
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survive. In total, 11 deaths were reported (8 %). We found 
6 % mortality in the contemporary group, compared with 
9 % in the group published before 2005 (p = 0.337).
Obstetric outcome Hypertensive disorders during preg-
nancy were reported in 28 women (18 %), progressing to 
pre-eclampsia/eclampsia in 15 women (10 %) and HELLP 
syndrome in 3 (2 %) women. These pregnancy-related hyper-
tensive disorders were not found more frequently in women 
with coronary artery dissection. Delivery was mainly by 
caesarean section (57 %). The caesarean section rate was not 
significantly different in women who presented with AMI 
during pregnancy (62 %) compared with women who had 
their AMI in the post-partum period (44 %, p = 0.08). In four 
women post-partum haemorrhage was described.
Late complications In 49 % of the women, 6-month fol-
low-up was reported. Of these women, 64 % had no compli-
cations during follow-up; in 21 %, a reduced cardiac function 
was reported. One woman needed a heart transplantation for 
progressive cardiac dysfunction. A few reported recurrent 
angina (n = 5) or coronary pseudoaneurysm/aneurysm (n = 2).
The aetiology differed depending on the time of presen-
tation during pregnancy (Fig. 2). In all, 87 % of the cases of 
coronary dissection presented in the third trimester or post-
partum period. Atherosclerosis peaked in the third trimester 
(42 % of all cases of atherosclerosis), whereas AMI with 
normal coronaries or caused by thrombosis or emboli was 
independent of the stage of pregnancy. Most women were 
treated non-invasively (n = 50) or with PCI (n = 47). Coro-
nary artery bypass surgery was performed in 22 women; in 
34 women, therapy was not clearly reported.
Maternal outcome
Comparison with other studies and characteristics of the 
contemporary group can be found in Table 2.
Cardiac outcome Seventeen women had had an episode 
of ventricular tachycardia, mostly as a presenting symptom. 
Additionally, six women suffered an episode of cardiac 
arrest. In six women, IHD was complicated by heart failure; 
cardiogenic shock occurred in one woman. Ten women had 
to be intubated during hospitalisation, of whom four did not 
Table 3 Overview and comparison of data described in the main literature concerning ischaemic heart disease during pregnancy and this study
Literature (women) Ladner et al. 
[5] (N = 151)
Satoh et al. [17] 
(N = 62)
James et al. [4] 
(N = 859)
Roth et al. [6] 
(N = 103)
This study
Overall (N = 146)
This study
Contemporary 
only (N = 57)
Years of inclusion 1991–2000 1981–2001 2000–2002 1995–2005 1978–2012 2005–2012
Mean age of women 
(years)
31–35 33 33 33 33.2 33.5
Most common timing of 
coronary event (N)
Post-partum 
(62)
Post-partum 
(28)
During pregnancy, 
not specified (626)
During pregnancy, 
not specified (46)
During pregnancy, 
third trimester (56)
During pregnancy, 
third trimester (25)
Most common location of 
AMI (N)
a Including ante-
rior wall (31)
Including anterior 
wall (215)
Including anterior 
wall (73)
Including anterior 
wall (80)
Including anterior 
wall (26)
Most common aetiology 
of IHD (N)
a Coronary 
dissection (14)
a Coronary stenosis 
(41)
Coronary dissec-
tion (46)
Thrombus/embo-
lism (20)
Most common risk factor 
for IHD (N)
HTa Smoking (9) a Smoking (46) Smoking (40) Smoking (17)
Maternal mortality (N) 7.3 % (11) 3.2 %a (2) 5.1 % (44) 11 % (11) 8 % (11) 6 % (3)
Most common (other) 
maternal cardiac 
complication (N)
a Cardiogenic 
shock (5), VF/
VT (5), HF (5)
a HF (9) VT (17) VT (3)
Most common maternal 
obstetric complication (N)
PIH (24) PPH (1) PPHa Pre-eclampsia (6) PIH (46) PIH (6)
Caesarean section rate (N) a b a 38 % (39) 57 % (75) 67 % (36)
Perinatal mortality (N) a a a 9 % (6) 4 % (5) 6 % (3)
Most common offspring 
complication (N)
Prematuritya Threatened 
premature 
delivery (3)
a a Prematurity (55) Prematurity (28)
Offspring mortality is defined as offspring death from 20 weeks of gestation up to 7 days post-partum; prematurity is defined as birth at < 37 
weeks of gestation
Missing data were excluded for analysis
aUnknown or not clearly reported data
bAt least seven women; incompletely documented
AMI acute myocardial infarction; HF heart failure; HT essential hypertension; IHD ischaemic heart disease; PIH pregnancy-induced 
hypertensive disorders, including pre-eclampsia, eclampsia and haemolysis, elevated liver enzymes and low platelets syndrome; PPH post-
partum haemorrhage; VF ventricular fibrillation; VT ventricular tachycardia
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botic disease and coronary dissection. Maternal and foetal 
complication rates, including maternal mortality, are high.
Though IHD is the most common cause of maternal car-
diac death in the UK,the estimated incidence of non-fatal 
IHD in the UK is only 0.7 per 100,000 maternities [11, 20]. 
As we only found two cases of IHD during pregnancy in 
our systematic search of three large university hospital data-
bases, IHD presenting during pregnancy is also rare in the 
Netherlands. This is in line with a recent prospective Dutch 
study that reported an incidence of 0.005 % [18].In a world-
wide registry describing 1321 pregnancies in women with 
heart disease, only 4 women with a first manifestation of 
IHD were reported [19].
Risk factors
Risk factors for IHD were present in both women in our 
case series and in the majority of the women in our review. 
This is in line with previous literature [4–6, 17–19]. Also, 
this indicates a large impact of lifestyle factors on IHD 
during pregnancy, as also described in the UK maternal 
death report [11]. In line with a recently published study in 
Japanese women, we observed less risk factors in women 
with coronary artery dissection or thrombus/emboli than in 
women with atherosclerosis as a cause of AMI, suggesting a 
different pathophysiology [17].
IHD, characteristics and treatment
Women in our review had a relatively high age compared 
with the average age at time of pregnancy in the USA [21]. 
This is comparable with previous literature [5, 6, 19]. Cor-
Offspring outcome
Offspring outcome is summarised in Table 3. Perinatal mor-
tality was 4 %. Reported causes of mortality included mater-
nal mortality (n = 2), non-cardiac congenital malformations, 
prematurity and suspected reduced placental perfusion dur-
ing cardiopulmonary bypass surgery. Overall median time 
of delivery was 36 (IQR: 34–38) weeks. In all, 56 % of the 
neonates were delivered prematurely (n = 55), which was 
significantly related to a higher rate of caesarean section 
(p = 0.012). Prematurity rate was 54 % in IHD manifest-
ing during pregnancy and 60 % in IHD manifesting during 
delivery or in the post-partum period. Mean neonatal birth 
weight was 2645 g (SD: 932 g), and around the 50th per-
centile for gestational age in almost all neonates. Low birth 
weight was reported in 19 patients (missing data in n = 107). 
Only one neonate was small for gestational age. Nine neo-
nates were reported to be admitted to the neonatal intensive 
care unit. The main reason was prematurity.
Discussion
In this case series and review, we add a significant num-
ber of new cases compared with previous reviews [6, 17], 
including 57 contemporary cases published after 2004. Our 
review also adds more detailed data concerning aetiology 
of IHD and maternal and offspring outcome. Our review 
confirmed that IHD is rare in pregnancy. Pregnant women 
with IHD present mostly with chest pain (95 %) in the third 
trimester or post-partum period. Risk factors are invariably 
present in atherosclerotic disease but less often in throm-
Fig. 2 Aetiology of ischaemic 
heart disease depending on the 
time of presentation during 
pregnancy (IHD ischaemic heart 
disease)
 
255
1 3
Neth Heart J (2015) 23:249–257
factors, such as the high rate of hypertensive disorders or 
maternal cardiac reasons for early pregnancy termination. 
Also, they may possibly be related to physicians’ reluctance 
for vaginal delivery in women with a recent myocardial 
infarction. Post-partum haemorrhage was described in 3 % 
of the women. This is comparable with women with known 
cardiac disease [23, 27–29] and only slightly more than in 
the general population [30, 31].
Offspring outcome
Perinatal mortality was increased at 4 % and mainly attribut-
able to maternal death and prematurity. Prematurity rate was 
3.4–13.2 times higher compared with the prematurity rates 
in healthy pregnant women [32–35]. Furthermore, it was 
even high compared with women with non-ischaemic heart 
disease [19, 23, 36].A high rate of induced early deliveries 
may be part of the explanation. However, prematurity rate 
was comparable in IHD manifesting during pregnancy with 
IHD manifesting during labour or in the post-partum period, 
suggesting an additional mechanism for the high prematu-
rity rates. Interestingly, in contrast to reports in women with 
non-ischaemic heart disease, the incidence of small for ges-
tational age was not elevated [25, 36, 37].
Limitations
By only including online available articles and articles in 
English, Dutch or German, we may have missed data. In 
our review, analysis was performed by excluding missing 
data, which might have led to deformation of the results. 
This is particularly important when missing data were abun-
dant (i.e. cardiac function during follow-up). Also, publica-
tion bias and selective reporting within studies, which could 
affect the cumulative evidence, could not be minimised. 
Because follow-up was insufficiently reported and limited, 
(late) maternal complications, including death, may have 
been underestimated.
Conclusions
In contrast to the atypical presentation in our case series, 
IHD during pregnancy mainly presents with chest pain and 
during the third trimester or the post-partum period. The 
main causes are coronary dissection and, in more recent 
cases, thrombus and embolism. Risk factors for IHD were 
present in most women with atherosclerotic disease, but 
less often in women with coronary dissection or thrombo-
sis/embolism. IHD during pregnancy or in the post-partum 
period has a high maternal mortality rate and high mater-
nal cardiac complication rates. Perinatal mortality and pre-
onary dissection is rare outside pregnancy, but it was the 
main cause of IHD in the women in our review. However, 
in our more recent cases, thromboembolic coronary events 
were seen equally frequently. Thromboembolic events may 
be largely attributed to pregnancy and its hypercoagulable 
state. Relatively high rates of coronary dissection during 
pregnancy have previously been described [17]. In line 
with previous studies, most cases of AMI presented in the 
third trimester and post-partum period [4, 5, 17]. Especially 
coronary dissection peaked in these periods, which may be 
explained by progressive connective tissue weakening and 
therefore susceptibility for dissection in late pregnancy. 
Pregnancy-related hypertensive disorders did not seem to 
contribute to the high incidence of coronary dissection, nor 
did inherited connective tissue diseases.
In contrast to the atypical presentation of our two cases, 
in our review, chest pain was the main presenting symptom 
of IHD. Most of the cases of AMI in our review could be 
detected on the ECG. In the UK maternal death report, sub-
standard quality of care was observed in 46 % of the women 
who died due to IHD. This often included delay of cardiac 
evaluation because IHD was not considered to be a possible 
diagnosis. Delayed recognition of IHD during pregnancy 
was also described in a recent Dutch study [18]. In pregnant 
women with chest pain, especially when they have risk fac-
tors, IHD should be considered and an ECG and laboratory 
investigation should be performed.
Maternal outcome
A relatively large percentage of women in our systematic 
review presented with serious complications directly due to 
AMI, including heart failure, a complication frequently seen 
in pregnant women with cardiac disease [19, 22]. In line 
with previous literature, mortality rate during pregnancy in 
women with IHD was higher than in pregnant women with 
cardiac disease overall [5, 6, 17, 19]. The slightly lower 
mortality rate in contemporary cases may be explained by 
improvement of coronary care.
Pregnancy-related hypertensive disorders found to be 
associated with IHD during pregnancy were seen more 
frequently compared with pregnant women with non-isch-
aemic heart disease [19, 23–25]. We observed a very high 
caesarean section rate of 57 %, which was even higher in 
contemporary cases. This is higher than the caesarean sec-
tion rate in healthy pregnant women (21 %) [26], higher than 
in a previous review [6] and higher than in women with con-
genital or valvular heart disease (38 and 42 %). However, 
caesarean section rate was comparable with women with 
cardiomyopathy (58 %) or known IHD (60 %) [19]. The 
high caesarean section rate was related to the high rate of 
premature deliveries. This high premature delivery rate and 
high premature caesarean section rate may be due to several 
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mature birth are increased in women with IHD and related 
to high caesarean section rate. Clinicians should seriously 
consider IHD when a pregnant woman presents with chest 
pain, in particular, in women with known risk factors for 
IHD. However, atypical presentation (i.e. collapse) is also 
possible.
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